Author Question: A nurse is preparing to administer a drug to a patient. The nurse understands that the route by ... (Read 62 times)

Caiter2013

  • Hero Member
  • *****
  • Posts: 607
A nurse is preparing to administer a drug to a patient. The nurse understands that the route by which bioavailability would most likely be affected is
 
  a. oral.
  b. subcutaneous.
  c. intramuscular.
  d. intravenous.

Question 2

A nurse is providing education to the unit on adverse drug reactions to reduce the number of medication errors.
 
  After the teaching has been conducted, the nurse asks, Which factor is a primary determinant of the intensity of an allergic drug reaction? The participants' best response would be the
  a. dose of drug ingested.
  b. body surface area of the patient.
  c. patient's degree of compliance.
  d. degree of sensitization.



Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

ANS: A
Oral drugs must undergo a first-pass effect, and those drugs are subject to the acid in the gut, which may affect bioavailability.
Subcutaneous, intramuscular, and intravenous medications are not subject to the first-pass effect or the acidity of the gut, therefore bioavailability is least likely to be affected by these routes.

Answer to Question 2

ANS: D
The intensity of an allergic reaction is determined primarily by the degree of sensitization of the immune system, not by drug dosage.
The intensity of an allergic reaction is largely independent of dosage. The dose of the drug is not necessarily related to whether the patient experiences an allergic reaction.
The body surface area is used to determine dose and is not a primary determinant of an allergic reaction.
The patient's degree of compliance is not relevant to the development of an allergic reaction.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

For a complete list of videos, visit our video library